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This report presents the results of survey research completed between April - September 2020 on behalf of the 
Drugs Policy and Social Inclusion Unit, and as part of a rapid impact assessment of COVID-19.  The results of two 
surveys assessing the impact of COVID-19 on people who use drugs and, drug and alcohol service providers in 




1. The Mini European Web Survey on Drugs: COVID-19 is a special round of the European Web Survey on 
Drugs, coordinated by the EMCDDA. Data collection took place between April – June 2020 via an online survey 
platform. The survey was targeted at those aged 18 years and over, with experience of illicit drug use, with a 
particular focus on recreational users and those using drugs in nightlife settings. There were 696 respondents 
from Ireland to the survey, the majority of respondents are cannabis, cocaine/crack cocaine or ecstasy/MDMA 
users.  
 
2. The Survey of Drug and Alcohol Services was conducted by IGEES / Research Services & Policy Unit in the 
Department of Health.  The survey was sent to drug and alcohol services in Ireland via email and was completed 
via an online survey platform. Data collection took place over a two-and-a-half-week period in August 
/September 2020.  Project leaders, service coordinators or equivalent staff members of drug and alcohol services 
from across Ireland were targeted. Email invitations were sent to over 500 addresses, and a total of 157 services 
completed the survey. Community Drugs Projects, Family Support Services and Counselling Services make up a 
large proportion of responding services, there is also a large representation form services based in Dublin.  
 
Key Findings 
Survey 1 Recreational Users 
 Most respondents reported either reducing (36%) or not using illicit drugs (24%), since the start of the COVID-
19 pandemic in Ireland. Fewer opportunities to use and reduced availability of drugs were the top reasons for 
reduced use of illicit drugs.  
 A total of 23% used more illicit drugs and 15% used the same amount. Boredom and anxiety (including anxiety 
related to the pandemic) were the top reasons provided by those who increased their illicit drug use.  
 Cannabis, cocaine/crack-cocaine and ecstasy/MDMA were the three drugs used most in the past 30 days, and 
in the 12 months before the pandemic.  
 Cocaine/crack-cocaine, ecstasy/MDMA, LSD, amphetamines and synthetic stimulants saw the biggest 
reductions in use during COVID-19 restrictions, with usage levels down by between 50% - 80% for these drug 
types when compared to the past 12 months.   
 Those using cocaine (64%) and ecstasy (55%) were most likely to report cessation, or a reduction in frequency 
or quantity used as a result of COVID-19 restrictions, when compared to before COVID-19. 
 Most respondents (77%) experienced at least some difficulty accessing drugs during the pandemic, and as a 
result, some reported buying in larger quantities or from different dealers.  
 Among the sample, 12% reported an increase in their intention to seek professional support in relation to drug 







Survey 2 Drug and Alcohol Services  
 Overall, service providers reported that clients’ physical and mental health, family relationships and financial 
circumstances were negatively affected by the COVID-19 pandemic   
o Almost all (96%) reported a negative impact of COVID-19 on their clients’ mental health   
o Restrictions on meeting people and having to self-isolate or cocoon were the elements of public health 
advice that clients found most challenging, with 74% and 68% services respectively rating these as 
highly challenging for their clients  
o It was felt that the homeless community were the worst impacted population group during the COVID-
19 pandemic, with 65% services reporting they were highly impacted  
 Service providers reported on changes in drug and alcohol use and drug markets since the COVID-19 
pandemic  
o Increased alcohol consumption was observed among clients to some extent by 92% services  
o The majority of services (87%) reported that clients are relapsing to some extent and 84% services said 
clients were increasing their drug use to some extent 
o Most services reported an awareness of difficulty accessing drugs (73%) and over half of services 
reported awareness of increases in the price of drugs (56%) and reductions in the quality of drugs 
(57%)  
 Service providers outlined the impact on service provision and staff  
o Overall, the majority of survey respondents felt their services were highly (52%) or extremely (22%) 
impacted by COVID-19  
o Face to face contact with clients (89%) and the availability of existing services (84%) saw the biggest 
reductions 
o Services have adapted to the challenges posed by COVID-19 by greater reliance on using telephone 
(93%) or online (80%) methods of communication and using personal protective equipment (75%) 
o The biggest impacts on staff have been in relation to working from home and work-life balance, with 
88% and 89% services respectively reporting impacts to some extent for these factors 
o The top-rated positive impact of the pandemic was ‘new ways of delivering services’ with 83% of 
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Chapter 1 Introduction 
1.1. Background  
 
The COVID-19 pandemic represents an increased risk for people who use drugs and alcohol, and a 
challenge for drug and alcohol service providers. The impact of the pandemic on service capacity, risks 
of disruption in access to services, clean equipment and medications, and what this means for service 
users has become an important topic of concern both in Ireland and internationally, with a number of 
policy and practice responses in development. Added to these challenges are, because of the health 
implications of using drugs, such as a reduced lung capacity and a weakened immune system, people 
who use drugs are more susceptible to the negative effects of COVID-19. Additionally, the mode of 
consumption for those who use drugs may also increase their risk of infection, due to sharing or 
reduced availability of equipment, and difficulty maintaining social distance and self-isolating.  
 
Overall, this research aims to explore how people who use drugs, as well as drug and alcohol services 
have been impacted by the COVID-19 pandemic in Ireland in order to learn from and improve 
responses to COVID-19 in the next period of recovery and resilience1.  
 
To achieve this aim, an online survey was conducted with drug and alcohol services in Ireland. Data 
from this survey, along with data from the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) Mini-European Web Survey on Drugs: COVID-19 have been analysed. The objectives of this 
report are to: 
 Describe the current policy context, including any guidance or recommendations that have 
been issued to drug and alcohol services in response to the COVID-19 pandemic.  
 Profile how people who use drugs recreationally have been impacted by COVID-19, 
including impacts on their drug use, how drugs are obtained and access to services. 
 Profile the ways services have altered their operations and the effects this has had on 
service provision, staff, and resources. 
 Describe how drug and alcohol services believe their clients have been impacted by the 
pandemic including health and social impacts, drug usage patterns, and impacts of public 
health advice.  
 Use results from both surveys to get a broader picture of the impacts of the pandemic for 
different groups of people who use drugs and alcohol, and drug and alcohol services. 
 
This report forms part of a wider Rapid Assessment of the Impact of COVID-19 on drug trends and 
services in Ireland being conducted by the Drugs Policy and Social Inclusion Unit in the Department of 
Health. Other methodologies being used as part of this assessment are; a literature review2, case 
studies and stakeholder engagement.  
 
                                                            
1 Department of the Taoiseach. (2020). Resilience and Recovery 2020-2021. Available from: 
https://www.gov.ie/en/publication/e5175-resilience-and-recovery-2020-2021-plan-for-living-with-covid-19/   






1.2. Policy Context 
 
Reducing Harm, Supporting Recovery; A health-led response to drug and alcohol use in Ireland 2017-
20253 (RHSR) is the current national strategy to address the harm caused by substance misuse in Irish 
society. This has been the strategy to promote an integrated public health approach to drug and 
alcohol misuse in Ireland and a move away from a criminal justice approach to drug use. With the 
strategy now approaching its mid-term review, the importance of understanding the impacts of the 
COVID-19 pandemic on drug trends and services in Ireland is all the more vital so that any new 
strategic actions taken can reflect the challenges of the current situation and ensure the continued 
relevance of the strategy for its lifetime, up to 2025. The public health approach that underpins the 
strategy is particularly relevant in light of COVID-19. Ireland is one of the countries who has clearly 
identified people who use drugs and alcohol as an at-risk group for COVID-194.  
 
1.3.  Evidence Review  
 
An evidence brief5 was conducted by the Health Research Board Evidence Synthesis Service to fulfil 
the ‘literature review’ component of the rapid impact assessment. The brief contained the most up to 
date evidence prior to this study on the response of the government and HSE to the pandemic in the 
drug and alcohol sector. The brief contained an investigation on the impact of COVID-19 in four 
countries, including an analysis of impacts in Ireland. It included evidence on the guidelines and 
supports that have been issued to drug and alcohol services in Ireland, and how services are 
restructuring to meet their clients’ needs. The full evidence brief is available on the HRB website and 
the key findings of the evidence brief for Ireland are summarised in this section, as they provide 
important context for the results in the current study report.  
 
1.3.1. Guidelines and Supports issued to Services in Ireland   
 
According to the evidence brief, the HSE developed new guidance for service providers working with 
people who use drugs - including those receiving Opioid Substitution Therapy (OST) - in response to 
the COVID-19 pandemic. In the brief, guidance was described as including induction to OST, and 
provision of OST, as well as specific guidance for people who use benzodiazepines and alcohol. The 
guidance also outlines circumstances where it may be necessary to undertake a rapid/emergency 
induction into OST, particularly in relation to vulnerable groups and the homeless community.6 A 
standard operating procedure for emergency induction to OST during the COVID-19 crisis has been 
                                                            
3 Department of Health. (2017). Reducing Harm, Supporting Recovery. Available from: 
http://www.drugs.ie/downloadDocs/2017/ReducingHarmSupportingRecovery2017_2025.pdf  
4 IIMHL and IIDL. (2020). Rapid Review on Coronavirus/COVID-19: Policies, Actions and Resources related to Drug and 
Alcohol Addiction across IIMHL and IIDL countries. Available from: https://www.iimhl.com/files/docs/IIMHL-
Updates/20200502.pdf  
5 Health Research Board. (2020). Impact of COVID-19 on drug services in four countries. Available from: 
https://www.drugsandalcohol.ie/32296/1/HRB_evidence%20brief%20for%20DPU%20Covid-
19%20rapid%20assessment_June_2020.pdf  






published7, as have detailed guidance on conducting remote clinical reviews via video link or 
smartphone8. Further, the brief outlines how protocols have been put in place for those required to 
isolate, such as the provision of OST treatment doses to clients, a family member or other appropriate 
person for the client’s use at home. Additional guidance also includes medication information e.g. 
securing the stored doses, general safety and record keeping, as well as guidance on overdose 
response and Naloxone, needle exchange provision, infection prevention and clients presenting in 
various settings, all in the context of COVID-199.    
 
1.3.2. Restructuring of services to meet needs 
 
According to the evidence brief, the focus for drug and alcohol services since the pandemic has been 
on continuity of care for those already in treatment and faster induction to treatment for those who 
are opioid dependent. According to the HSE, an additional 647 people commenced OST in the period 
January to end May 2020. It was further noted in the brief that the aim has been to reduce the 
potential for viral transmission among this cohort and to reduce the risk of harm to individuals. 
Administrative changes and further resources have allowed faster processing of clients into treatment 
and have supported cocooning and isolation of vulnerable homeless people. An extra 500 single rooms 
with bathrooms have been made available for this group. The evidence brief outlined how the wait-
time for methadone treatment has been reduced from 12 weeks to 3 days and there has been an 
increase in Benzodiazepine prescriptions to allow easier stabilisation of drug use during isolation. 
Outreach services have been tasked with providing information on COVID-19 to clients, for example 
some services provided information on COVID-19 when delivering needle exchange services.  
 
While additional resources came on stream in response to the pandemic, the HSE have noted that the 
initial response relied on existing capacity. 
 
The HRB noted that Regulatory changes to the Medicinal Products (Prescription and Control of Supply) 
Regulations 2003 and the Misuse of Drugs Regulations 2017 have also been temporarily amended to 
ensure that clients can continue to access their treatments and other medicines, as well as reducing 
the burdens on prescribers. These amendments allow for the electronic transfer of prescriptions from 
doctors to pharmacists, change the way prescriptions can be repeated and extend the life of some 
prescriptions from 6 to 9 months, allowing pharmacists to provide additional supplies of prescriptions 
where safe to do so thus reducing the need for healthcare visits.   
 
The HRB also presented evidence that drug and alcohol services have also adapted to remote working 
practices, with eConsultations, online group sessions, telephone consultations, and delivery of 
medications now taking place across the country. In these instances, HSE services have been provided 
                                                            
7 HSE. (2020). Example SOP for emergency induction of OST during COVID CRISIS. See 
https://www.hse.ie/eng/about/who/primarycare/socialinclusion/other-areas/health-inequalities/example-sop-for-
emergency-induction-of-ost.pdf  
8 HSE. (2020). Ways of Working: Guidance for Addiction Services on Remote Consultations. See:  
https://www.hse.ie/eng/about/who/primarycare/socialinclusion/other-areas/health-inequalities/remote-
consultations.pdf  






with appropriate software and in some cases, smartphones were provided to clients isolating at home 
or in an isolation hub.  Although there is much debate on the benefits of online services versus face to 
face, they have allowed services to continue to provide structure and support for their clients. There 
have been some very successful uses of remote services, for example Better Together, a programme 
using online video conferencing for those in recovery in the Southeast. 
 
It was outlined in the evidence brief that drug and alcohol clinics have also implemented social 
distancing measures and in some cases, clients were provided with letters stating the date and time 
of their appointment to ensure they had permission to travel during periods of restricted movement. 
 
According to the HRB review, there remain significant challenges for drug and alcohol users in light of 
COVID-19, not least due to the higher rates of chronic conditions such as chronic respiratory diseases 
amongst people who use drugs, and underlying risk factors for drug and alcohol use. Some individuals 
may not be able to self-isolate if they are sleeping rough or using short term accommodation. There 
are also mental health risks associated with isolation while quarantining, as well as other stresses that 
can lead to relapse. There is a greater risk of overdoses with some individuals stockpiling drugs, as 
well as insufficient access to clean equipment, while the sharing of equipment may also contribute to 





Chapter 2 Survey of Recreational Users 
2.1 Overview of the Survey  
 
The Mini European Web Survey on Drugs: COVID-1910 is a special round of the European Web Survey 
on Drugs, which is coordinated by the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). The EMCDDA includes the 28 EU member states, Norway and Turkey. The survey aimed 
to gather information on how patterns of drug use, access to health services and the drug market may 
have changed in Europe during the COVID-19 pandemic. It is also hoped that the survey would 
contribute to the emerging knowledge base on COVID-19 and Europe’s response to it, thus potentially 
helping to protect the health of people who use drugs, improve drug services and raise awareness of 
market changes. 
 
Data from people who use drugs tends to come mainly from small scale studies of specific ‘heavy user’ 
groups, for example, people undergoing treatment, while general population surveys typically do not 
have sufficiently large samples of drug users to provide robust information. The European Web Survey 
on Drugs is an online survey aimed at drug users specifically, aiming to bridge this data gap. In Ireland, 
the survey was intentionally targeted at social or recreational drug users, i.e. those who do not 
typically present to services and as such, are not captured in administrative and service datasets.  
 
This special round of the survey was split into five sections dealing with different topic areas, as 
summarized in the below table.  
 
 
Table 1 Structure of Survey of Recreational Users 
Section Themes explored 
Socio-demographics Gender, year of birth, type of area.  
COVID-19 status Engagement with behaviours related to COVID-19 and restrictions. 
Drug Use Drug use in the past 30 days, drug use in the past 12 months, change of 
drug use due to restrictions, change in means of drug use, overall trend of 
use, and reasons for this trend.  
Access to Services Where syringes obtained in past 12 months and since COVID-19 
restrictions, access and availability of injection materials, change in 
professional support intentions, and change in use of online supports.  
Drug Market Drugs obtained since COVID-19 outbreak, difficulties with access, means 











2.2 Methodology  
 
The Mini European Web Survey on Drugs: COVID-19 was conducted by the EMCDDA using the online 
survey platform EUSurvey; a platform supported by the European Commission. Data collection took 
place during initial wave 1 COVID-19 restrictions in Ireland. The survey was launched in April 2020, 
made available in 21 languages and received over 11,100 responses by the beginning of June 2020 
when it was closed. There were 696 total respondents from Ireland. Findings from these respondents 
only are presented in the report. The survey was promoted by the HSE site Drugs.ie with a target 
audience of night life drug users. 
 
Sample and Scope of the Data 
The survey targeted adults aged 18 years or over with experience of illicit drug use, with the aim of 
gathering information on changes in drug consumption behaviours in Europe due to COVID-19, and 
also included questions on help-seeking and perceptions of service availability. In Ireland the survey 
was intentionally promoted among recreational users and night life attendees who are hard to reach 
and may not present to drug services. The respondent recruitment strategy reflected this intention, 
and in particular, the HSE have noted that roughly 300+ respondents were directly linked with a paid 
promotion in a sub cultural dance music magazine. The cohort targeted for this survey tend to be 
absent from service-related or administrative data sets in an Irish context.  
 
This survey was part of a rapid response to the evolving impacts of COVID-19, and as outlined, the 
findings represent the views of a small group of people who use drugs and responded to the survey in 
Ireland. As such, there should be cautious interpretation of results and results should not be 
considered generalisable to all illicit drug users in Ireland or the Irish population.  
 
Results are presented in Section 2.3.3 on the availability of clean injecting equipment since wave 1 
COVID-19 restrictions were in place, for people who inject drugs. However, it should be noted that 
because those who inject drugs were not targeted for this survey, the number of responses to these 
questions are very low and should be interpreted cautiously as indications only of possible wider 
patterns. A profile of all survey respondents is presented in Section 2.3. 
 
Analysis 
An anonymous microdata file for Ireland was accessed from the EMCDDA via the Health Research 
Board. Data was cleaned and edited which involved the following steps; conversion of text data to 
numerical data, generation of new variables for multiple response questions, the creation of 
subgroups for analysis and labelling of all variables. Analyses were then run for each question and 
graphs generated. These steps were performed in both Microsoft Excel and Stata version 16. 
Qualitative responses were not formally analysed for this report; however, a brief summary of 






2.3 Findings  
 
This section presents the findings from Ireland of the Mini European Web Survey on Drugs: COVID-19, 
hereby referred to as the Survey of Recreational Users. Survey results are presented in graphs as 
frequencies and/or percentages. Frequencies are used in graphs where there are less than 100 people 
in any subgroup presented, e.g. people who use a certain drug. Where appropriate, questions are 
analysed by subgroups; gender, age, area, and drug type. Drug types presented in this analysis 
correspond with the three main drug types used by respondents in the past 12 months; cannabis, 
cocaine/crack-cocaine, and ecstasy/MDMA. 
 
 
2.3.1 Demographics and COVID-19 Responses  
 




The majority of respondents are male, n=494, representing over 70% of the sample. Most respondents 
are aged in their twenties, just n=198, 30% of the sample are aged over 30. Over half of survey 
respondents live in a city (n= 354, 54%), nearly a third in a town (n=203, 31%) and the lowest number 
live in a village (n=99, 15%).  
 
Based on findings of the Drug Prevalence Survey11, a general population survey on drug use in Ireland, 
this sample is in line with the overall population who use drugs with regards to age and gender, with 










                                                            

















     Figure 2 Engagement with COVID-19 restrictions 
 
         Note: Admitted to hospital was also a response option, no respondents from Ireland selected this. 
 
In terms of engagement with COVID-19 restrictions, the majority of respondents engaged in home 
isolation (i.e., government asked everyone to stay in isolation at home) (n= 536, 78%). While over two-
thirds engaged in physical isolation (e.g., avoiding public transport and social gatherings, 
working/studying from home) (n=478, 69%). Just n=17 respondents (2%) engaged in home quarantine, 
that is, they tested positive for COVID-19 and stayed at home, and no respondents in Ireland tested 
positive for COVID-19 and were admitted to hospital. A total of n=50 respondents (7%) said they did 
not engage in any of these behaviours. 
 
There is little variation in numbers engaging in these behaviours by age and gender. The group with 
the highest rates testing positive for COVID-19 and having to stay at home are those aged 22-24, with 
n=7, 4% in this cohort having done so. There is similarly little variation in these behaviours among 




2.3.2 Consumption of Drugs 
 
This section provides a summary on the consumption of drugs and the changes in usage patterns 
among respondents due to COVID-19 and associated wave 1 restrictions. Section 2.3.2.1 compares 
consumption in the past year with recent consumption patterns and looks at usage patterns among 
frequent users. Section 2.3.2.2 examines overall illicit drug use since the start of the pandemic and 
changes to drug use for each drug type. Section 2.3.2.3 examines the changes in method of use that 


















2.3.2.1 Recent consumption compared to consumption in past year  
 
Figure 3 Substance use in 30 days prior to survey 
 
 
In relation to drug consumption, respondents were first asked about their recent drug use, that is to 
provide details of their use of each drug presented, in the 30 days prior to taking the survey. Cannabis, 
cocaine/crack-cocaine and ecstasy/MDMA were the three drugs used most by respondents in the past 
30 days, which gives an indication of use during COVID-19 restrictions. Cannabis was used by n=440, 
64% of respondents. Cocaine/ crack-cocaine was used by n=200, 29% respondents and ecstasy/MDMA 
was used by n=79, 12%. Less than 10% of respondents used LSD, amphetamines, heroin and other 
opioids in the 30 days prior to taking the survey. Other synthetic stimulants (e.g. cathinones) and 
synthetic cannabinoids were the least used drug types among respondents in this time frame.  
 










































































Respondents were then presented with the same list of drugs and asked to provide details of their use 
in the past 12 months. Consumption in the past 30 days and the past 12 months are presented in the 
above graph. Cannabis, cocaine/crack-cocaine and ecstasy/MDMA were similarly the three drugs used 
the most by respondents in the past year.  
 
Although it is difficult to compare one month with a year of drug use, it would appear that cocaine, 
ecstasy/MDMA, LSD, amphetamines and synthetic stimulants were the drug types that saw the 
biggest reductions in use during COVID-19 restrictions, with usage levels down by between 50-80% 
for these drug types in the past 30 days when compared to the past 12 months.   
 
 
           Figure 5 Usage patterns among those who used each drug type frequently in the past year 
 
Based on those who used each drug type once a week or more often in the past 12 months, cannabis: n=335, 
ecstasy/MDMA: n=13, cocaine/crack-cocaine: n=90, amphetamines: n=20, heroin: n=22, LSD: n=6, synthetic 
cannabinoids: n=5, other synthetic stimulants: n=1 and other opioids: n=13. 
 
 
The above graph depicts recent usage patterns (in the past 30 days prior to the survey) for frequent 
users of each drug type. Frequent users are defined as respondents who used each drug once a week 
or more often in the past 12 months. Although numbers are low for frequent users of some drug types, 
the majority of frequent cannabis, heroin, and other opioid users, maintained frequent use during 
COVID-19 restrictions. Frequent ecstasy/MDMA users on the other hand, exhibited less frequent use 


































Frequent Users' Pandemic Use




2.3.2.3 Overall illicit drug consumption patterns and changes in use for each drug type 
 
Figure 6 Overall illicit drug use since the start of the pandemic 
 
Based on those who used at least one of the presented drug types in the past 12 months. 
 
 
Respondents who had used any of the presented drugs in the past 12 months were asked about their 
overall use of illicit drugs since the start of the COVID-19 pandemic in their country. Overall, there was 
reduced illicit drug use since the start of the pandemic. A total of n=154 respondents, 24% reported 
that they had not used illicit drugs and a further n= 236, 36% said they had used less illicit drugs since 
the start of the pandemic. Close to a quarter, n=148, 23% respondents used more illicit drugs during 
the initial COVID-19 restrictions, while n=100, 15% used the same amount.  
 
Respondents aged 31-35 were most likely to have used more illicit drugs during restrictions while 
those over 45 years old were most likely to have used the same amount. Females were more likely 
than males to have not used illicit drugs and similarly, there were more younger users than older users 
who had not used illicit drugs since the start of the pandemic. Cannabis users were more likely to 

















































































Table 2 Change in drug use as a result of wave 1 COVID-19 restrictions  
Stopped, used less 




Used in different 








































































































Based on respondents who have used each drug in past 12 months; Cannabis users = 573, Ecstasy users = 418, Cocaine 
users = 472, Amphetamine users = 122, Heroin users = 36, LSD users = 175, Synthetic cannabinoid users = 30, Synthetic 




Table 2 above shows the number and percentage of respondents who changed their drug use patterns 
since wave 1 restrictions were introduced, for each drug type. As suggested by the recent drop in use 
for these drug types, those using cocaine, and ecstasy, were most likely to report stopping or reducing 
their use (combined), with n= 301, 64% and n= 231, 55%, having done so respectively. Many 
respondents reported increased cannabis use during the pandemic, with n= 217, 38% having started 
to use this drug, using more frequently or using in greater amounts (combined). For most other drug 
types, the largest proportion have not changed their usage patterns since restrictions began, though 
there are still considerable numbers, relative to the number of users, reducing their use of 
amphetamines, heroin, LSD and cannabis.  
 
The changes in drug use patterns in wave 1 are further analysed in Table 3 for the three drug types 
with the largest number of users and thus having the biggest impact on overall patterns of illicit drug 










Table 3 Detailed change in use as a result of wave 1 COVID-19 restrictions: cannabis, ecstasy/MDMA and 
cocaine/crack-cocaine users  
Cannabis Ecstasy Cocaine 














































































































Total users  573 418 472 
Based on respondents who have used each drug in the past 12 months  
* Overall categories combine respondents who selected any of the corresponding response options, respondents could 
select more than one option but are only counted once in the overall numbers. 
 
For cannabis users who have reduced their use, the highest number have been using less frequently 
with n= 96 users, 17% selecting this option. There is a considerable proportion also who have stopped 
using altogether, n= 69, 12%. However, there are more cannabis users increasing their use, which is 
mainly down to individuals using more frequently. A total of n= 186, 32% cannabis users are using 
more frequently since COVID restrictions have been in place. To a lesser extent, cannabis users are 




In terms of ecstasy/MDMA usage, the reduction in usage is largely accounted for by the n= 191, 46% 
users who have stopped using ecstasy/MDMA altogether. A further n=38, 9% users are using less 
frequently. There is a slightly different pattern among cocaine users, n=186, 39% have stopped using 
cocaine and n= 115, 24% are using cocaine less frequently.     
 
For those who are using in a different form, by a different method or using a different substance, the 
main move is towards alcohol, likely influenced by the fact that it was easily accessible during the 
pandemic compared to illicit drugs. The highest rates of a move towards alcohol are among cannabis 
users, where n= 68, 12% are using more alcohol instead. 
 
Frequent Users  
When a sub-sample of frequent users of the three main drug types was analysed three key trends 
were apparent. Overall, a lower proportion of frequent users stopped using each drug altogether, with 
a higher proportion of frequent users, particularly cocaine and ecstasy users, using less frequently 
rather than stopping use. For frequent cannabis users, there are even more using more frequently. 
There are also slightly greater proportions of frequent cannabis and cocaine users using in greater 
quantities.  
  
2.3.2.3 Changes in method of use and reasons for changed usage overall 
 
                   Figure 7 Changes in method of drug use due to COVID-19 restrictions 
 
Based on those who used at least one drug type in past 12 months. Those who haven’t used 
drugs by each method have been excluded from analysis. 
 
Respondents were also asked if the way they use drugs was impacted by COVID-19 restrictions. 
Smoking was the method that saw the biggest increase (n= 166, 31%) in use during COVID-19 
restrictions, while sniffing saw the biggest decrease (n= 256, 59%). There were also n=198, 55% 
respondents who reduced their intake of drugs by swallowing. This follows the change in usage 
patterns, with a large number of respondents stopping or reducing their use of cocaine (64% of 
cocaine users) and ecstasy/MDMA (55% of users) and similarly a large number starting or increasing 
their use of cannabis (38% of cannabis users).  

























                Figure 8 Reasons selected by respondents for decreased illicit drug use 
 
Based on those who used less illicit drugs since the start of the pandemic, n=236. Note: Full response codes are as 
follows; Fewer opportunities to use drugs (e.g., closure of clubs/bars, restrictions on gatherings); Reduced 
availability of drugs to buy; Reduced ability to collect drugs (e.g., can’t leave home); Living arrangements make it 
difficult to use drugs; Saving my money due to future financial uncertainty; Worried about effects on my health; 
Loss of income/less money to buy drugs. 
 
The most common reason provided by respondents who reduced illicit drug use during restrictions 
(n=236) was that there were fewer opportunities to use drugs, for example due to the closure of clubs 
and bars and restrictions on gatherings, n= 154, 65% respondents selected this reason. The second 
most cited reason was the reduced availability of drugs to buy, with n= 116, 49% selecting this option. 
A third of respondents who used less drugs (n=80, 34%) said this was due to a reduced ability to collect 
drugs, i.e. they couldn’t leave home due to restrictions. 
        
                      Figure 9 Reasons selected by respondents for increased illicit drug use 
 
Based on those who used more illicit drugs since the start of the pandemic, n=147 
Note: Full response codes are as follows; Boredom; Anxiety/to cope with COVID-19; Because I 
stockpiled drugs; More money to buy drugs; Greater ability to collect drugs (e.g., online); Greater 
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For those who used more illicit drugs during restrictions (n=147), the most common reason for doing 
so was boredom, with n= 118, 80% respondents selecting this option. Over half of respondents (n=79, 
54%) also said they used more illicit drugs due to anxiety or in order to cope with COVID-19.  
 
2.3.3 Service Availability and Use 
 
This section provides a summary of the impact COVID-19 has had on the availability of certain drug 
and alcohol services according to respondents, and the intentions of respondents to access services 
during the pandemic. In particular in relation to availability of services, Section 2.3.3.1 examines the 
availability of clean injecting equipment since COVID-19 restrictions have been in place, for people 
who inject drugs. The number of people who inject drugs responding to these questions is very low 
and therefore very limited conclusions can be drawn from these results. Section 2.3.3.2 looks at 
support behaviours and intentions.  
 
 
2.3.3.1 Access to clean injection materials 
 
Figure 10 Where syringes were obtained in the past 12 months and since COVID-19 restrictions have been in place 
 
Note: Only people who injected in the past 12 months were asked this question (n=45), but not all of these respondents 
answered the question.  
 
 
The above graph displays where those who have injected drugs in the past year obtained their syringes 
both in the past 12 months [blue bars] and during COVID-19 restrictions [orange bars]. Although these 
figures are not directly comparable, it gives an indication of the change in access to injection materials 
that has occurred, with some reductions in access to syringes via services like drop-in centres and 
outreach workers. There are also some reductions in access to syringes through regular contacts, such 







































Figure 11 Change in access to injection material and adequacy of injection material for users 
 
Note: Only people who injected in the past 12 months were asked this question (n=45), but not all of these respondents 
answered the question. No respondents answered more accessible than usual.  
Full response code ‘Have not injected drugs’= ‘I have not injected drugs after the COVID-19 restrictions’ 
 
 
Respondents who inject drugs were also asked if their access to clean injection materials had changed 
as a result of COVID-19 restrictions and if they had enough injection material to always use a clean 
syringe, since COVID-19 restrictions were put in place.  Again the low number of respondents to these 
questions limits the conclusions that can be drawn, however it appears that there is a cohort of those 
who inject drugs who experienced reduced access to clean injecting materials during COVID-19 
restrictions and who did not have enough injection materials. No respondents answered that clean 
injection materials were more accessible than usual. 
 
 
2.3.3.2 Support behaviours 
 
This section deals with respondents’ intentions around, and use of supports. It is important to note 

































Figure 12 Change in intentions to seek professional support for drug use 
 
Based on those who used at least one drug type in the past 12 months. 
 
 
Respondents were asked if there had been a change in their intention to seek professional support 
(counselling or drug treatment) to reduce or abstain from use of illicit drugs since COVID-19 
containment measures were introduced. Although the vast majority of respondents (n=516, 83%) did 
not experience any change in their intentions during the pandemic, n=74, 12% respondents did report 
an increase in their intentions to seek professional support. When results are compared by gender 
and age, a greater proportion of females (n=29, 18%) reported an increase in their intentions to seek 
professional support when compared to males (n=41, 9%). Those over the age of 30 also saw greater 
increased intentions to seek support when compared to younger respondents. There was little 
variation in intention to seek professional support during the pandemic among users of the three main 
drug types analysed; cannabis, cocaine, and ecstasy.  
 
Overall, n= 32, 5% of all respondents reported they were less likely to seek professional support during 
the first wave of the pandemic. Intentions to seek support were also examined among those who used 
more illicit drugs during the pandemic, those who used the same and those who used less. The biggest 
increased intentions were among those who used more drugs during the pandemic, (n= 22, 16%) 
followed by those who used less (n=28, 13%). Those who reported no change in use were least likely 



















































































Figure 13 Change in use of online supports for drug use 
 
Based on those who used at least one drug type in the past 12 months. 
 
 
Respondents were also asked if they had experienced a change in their use of online or remote 
professional support services such as phone, video and\or web-based drug services to seek support 
for reducing drug-related risk behaviours and\or drug use, since wave 1 COVID-19 containment 
measures were introduced. Again, the vast majority (n= 556, 90%) experienced no change to their 
behaviours, while n=41, 7% respondents increased their use of online support. Those aged 36-45 had 
the largest proportion with increased use at n= 13, 17%. This age group represent a third of heroin 
users in the sample. The HSE have noted that this cohort may be linked with addiction services and 
could represent an aging cohort who were offered online support. Again, there was little variation in 
use of online services among the three main drug types analysed. Just n=19, 3% of all respondents 
reported a decrease in their use of online supports. 
 
 
2.3.4 Drug Markets 
 
This section provides a summary on the impact COVID-19 has had on drug markets and the availability 































































Figure 14 Obtainment of illicit drugs since the pandemic and drug types obtained 
 
                                                                    Based on those who obtained/attempted, n=433  
 
Well over half of respondents (n=435, 63%), have obtained or attempted to obtain illicit drugs since 
the outbreak of COVID-19. By far the drug most obtained by this group was cannabis, with n=338, 78% 
of those who tried to obtain drugs having obtained cannabis on their last occasion. This is to be 
expected given the reported increases in cannabis use during the pandemic. Despite the reductions in 
cocaine use reported by users, it remains the second most obtained drug. Cocaine was obtained by 
n= 150, 35% respondents on their last occasion. 
 
Figure 15 Difficulty accessing illicit drugs due to COVID-19 
 



















































































































Of those who obtained or attempted to obtain drugs since the pandemic (n=434), a total of n=169, 
39% respondents reported that they experienced moderate or extreme difficulties in accessing illicit 
drugs because of COVID-19. There were considerably greater proportions of men (n= 140, 43%) 
reporting having difficulties than women (n=25, 25%), while younger cohorts also reported more 
difficulties than older respondents. When the area respondents are living in are compared, we see 
that city dwellers experienced more difficulty than those living in towns and even more so compared 
to those living in villages. Finally, cannabis users experienced more difficulties accessing illicit drugs 
than cocaine and ecstasy users. 
  
 
     Figure 16 Change in way illicit drugs obtained compared to before restrictions 
       
     Based on those who obtained/attempted, N= 431 
 
 
Respondents were asked to specify if the way they obtained drugs had changed when compared to 
the way they obtained drugs before COVID-19 restrictions were in place. Of those who obtained or 
attempted to obtain drugs since the pandemic (n=431), over a third did not make any changes to the 
way they obtained drugs (n=150, 35%). Many respondents, however, did obtain larger quantities (n= 
148, 34%), less frequently (n=72, 17%) or used different dealers (n= 122, 28%). There were some 
respondents (less than 10%) using more delivery methods, and a small number (less than 5%) 
obtaining drugs through the internet or darknet more than they did before COVID-19. A total of n=56, 
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      Figure 17 Change in the purity, price and quantities of drugs obtained 
 
      Based on those who obtained/attempted, Purity (n) = 429, Price (n) = 428, Quantity (n) = 424.  
 
 
Over half of respondents reported that there was no change to either the purity, price or the quantity 
of drugs they obtained. Considerable proportions of respondents however, reported increased price 
(n=171, 40%) for the drugs obtained, lower purity (n=96, 22%), as well as lower quantities obtained 




2.3.5 Additional Comments from Respondents 
 
Respondents had the opportunity at the end of the survey to provide additional comments concerning 
the impacts COVID-19 has had on drug use patterns. Approximately 15% of participants provided 
comments for this section. Comments were reviewed and a summary of responses are presented 
below. It is important to note that these qualitative findings are presented to give an indication of the 
type of responses coming up in this question. A formal qualitative analysis was not undertaken as part 
of this impact assessment. Findings in the blue box below represent the opinions of a few individuals 























Change in drug and alcohol consumption 
The pandemic and associated restrictions have resulted in some changes to usage patterns among 
respondents. Some survey respondents commented on how their cannabis use had increased but 
their use of ‘party drugs’ or ‘hard drugs’ had decreased. A few respondents commented that using 
cannabis helped them to relax and cope with the anxiety associated with lockdown measures, while 
others commented on how the pandemic had given them time to reflect on their drug consumption 
levels. Some of these respondents felt they were now going to reduce their use more permanently.  
A small number of respondents however, highlighted that their alcohol consumption levels had 
increased during the lockdown months, with a few others mentioning reduced tobacco use.  
 
Difficulties in obtaining illicit drugs during COVID-19 
Due to the restrictions in place since the outbreak of the pandemic, there have been reduced 
opportunities to use drugs as well as difficulties accessing drugs for many respondents. A few 
respondents reported taking risks and trying to source drugs from untrusted supply chains and 
dealers. A small number of respondents commented that the price of certain drugs like cannabis 
and ketamine had increased substantially during COVID-19. Respondents reported with the 
increased demand and price of cannabis continuing to increase, the supply of cannabis slowed 
down. A small number also commented that the purity of some drugs had decreased during the 
lockdown months. One respondent also highlighted that the price of cannabis was more expensive 
in rural towns and they were forced to travel to bigger cities to secure cannabis. This respondent 
also commented that harm reduction supplies were in low supply in rural towns. 
Another difficulty experienced by a few respondents was the increased policing of drug 
transactions, with the increased policing of cannabis particularly highlighted by these respondents. 
The ‘Stop and Search’ campaign the Gardai were operating during the lockdown months was 
mentioned by a few respondents as source of increased stress and anxiety. 
 
Wider impacts of the pandemic 
A few respondents mentioned some of the wider impacts the pandemic is having on people who 
use drugs. These included; negative impacts on personal relationships; the lack of stability leading 
to relapse for some; increases in overdoses and other crises; increased demand on waiting lists for 
services; and the impacts for the homeless community. 
 
Comments on survey coverage 
Finally, a small number of respondents made comments on the coverage of the survey, noting that 
drug types like alcohol, GHB, magic mushrooms, tablets and ketamine, as well as other methods 











Drug use patterns were examined in several ways in the survey and analysis. Over half of the sample 
n= 390, 60% reported having not used or used less illicit drugs since the outbreak of COVID-19 in 
Ireland and during the first wave. A further n= 100, 15% used the same amount and n= 148, 23% used 
more illicit drugs. Usage patterns since the pandemic differ depending on the drug type used and 
frequency of pre-pandemic use. With cannabis, cocaine and ecstasy/MDMA users representing the 
majority of respondents to the survey, these user groups have been examined in more depth than 
other groups.  
 
For cannabis users, usage appears to have increased somewhat, with a total of 38% of users starting 
to use, using more frequently or using in greater quantities (combined). This is mostly accounted for 
by more frequent use. Cocaine and ecstasy users reported less use, with 64% and 55% respectively 
reporting stopping use, using less frequently or using in smaller quantities (combined). For ecstasy 
users, the vast majority of those reducing use have stopped altogether. For cocaine users, there is 
more of a mix with some stopping use totally and others using less frequently.  
 
The results show that the observed reductions in illicit drug use overall are largely accounted for by 
the reduction in use of cocaine/crack-cocaine and ecstasy/MDMA: a total of 345 respondents fell into 
one or both of these user groups, stopping or reducing their use. Cocaine and ecstasy are both 
stimulants and so are typically used as party drugs at nightclubs, concerts, festivals or other events. 
With COVID-19 restrictions in place, and less access to the nighttime economy, opportunities to use 
these drugs has been severely limited. Restrictions on the number of visitors to your home also 
prevented attendance at house parties. Across Europe, interest in these types of drugs used in social 
settings was down as a result of the restrictions in place12.  Some respondents highlighted this pattern 
when providing additional comments, explaining that without these social events taking place their 
use of these types of drugs was reduced, with cannabis a more popular choice for use at home. 
Wastewater studies in some European cities (Amsterdam, Castellon, Helsinki) have also supported 
these reported new patterns of use.13  
 
Some respondents reported that due to COVID-19 restrictions they are using in a different form, by a 
different method or using a different substance. Using more alcohol instead of illicit drugs was 
included in this category. Cannabis users showed the highest proportions changing their drug use in 
this way (n=82, 14%), which was largely accounted for by a move to alcohol. A total of n=68, 12% of 
cannabis users reported using more alcohol instead during restrictions. Elsewhere in Europe, there 
were reports of a greater interest in some newer substances, with the appearance of benzodiazepines 
on the new psychoactive substances market, possibly driven in part by shortages of more established 
                                                            
12 EMCDDA. (2020). European Drug Report: Trends and Developments. See   
https://www.emcdda.europa.eu/system/files/publications/13236/TDAT20001ENN_web.pdf  






drugs14. However, and by comparison, there are very low numbers (>5) across each drug type, 
reporting using new psychoactive substances among this sample of people who use drugs 
recreationally in Ireland. This is in line with general low levels of new psychoactive substance use in 
Ireland, according to the HSE. Overall, a change of method or substance during the pandemic was not 
very prevalent among respondents.  
 
 
Drug Markets  
Of those respondents of the survey who obtained or attempted to obtain drugs since the outbreak of 
COVID-19, n=335, 77% reported some level of difficulty in accessing drugs. Again, this is likely linked 
to the closure of the nighttime economy as well as the impact of restrictions on typical distribution 
and access routes in Ireland. Reductions in the availability of cannabis, cocaine, heroin and synthetics 
(amphetamines and MDMA) have been reported elsewhere and in several European countries14.  
 
According to the EMCDDA report on drug markets15, in general in Europe, trafficking using couriers on 
public transportation, including commercial airlines, saw some disruption. However, there did not 
appear to be a major disruption to drug trafficking activities using other methods. There has been 
continued commercial transportation of goods throughout the European Union and disruptions to the 
supply chain have been largely at the distribution level, due to social distancing and other restrictions. 
There have been reports of inflated retail prices for both cannabis resin and herbal cannabis due to 
shortages of cannabis resin and possible stockpiling of herbal cannabis by users. The availability of 
heroin has decreased in some areas, with the price increasing as a result. The production of synthetic 
drugs like MDMA has continued in Europe though there are widespread reports of reduced demand 
for these drug types typically used in recreational settings. There is little evidence of disruption in the 
cocaine market. The current instability has however, led to an increasingly volatile environment for 
criminal businesses along the supply chain in Europe and appears to have resulted in increased levels 
of violence among mid-level suppliers and distributors, at least in some European countries.  
 
In terms of changes to the price and quality of drugs in Ireland, just n=14, 3% respondents reported a 
decrease in the price of drugs since the outbreak of COVID-19 and during the first wave, while n=171, 
40% reporting an increase in price. A total of n=96, 22% of respondents reported that the 
purity/strength of the drugs obtained was lower. According to the EMCDDA, there have similarly been 
increases in prices reported for cannabis, cocaine, heroin and synthetics in a number of countries in 
the EU14. Reduced purity or quality has also been reported in Europe, particularly in relation to 
cocaine, heroin, amphetamine and methamphetamine15. 
 
Respondents of the survey have had to adapt to the challenges in accessing drugs during the 
pandemic, with some turning to new dealers or buying in larger quantities on an occasion. A small 
number of respondents are engaging more in alternative means of accessing drugs, like home and 
                                                            
14 EMCDDA. (2020). European Drug Report: Trends and Developments. See   
https://www.emcdda.europa.eu/system/files/publications/13236/TDAT20001ENN_web.pdf  





postal deliveries and purchasing via the internet, though less than 10% are engaging in any of these 
methods.  
 
The internet, dark net and communication apps are being used more to source drugs by users across 
Europe. Home deliveries, less face to face interactions and cashless exchanges are all increasing 
features of the market. Drug drops, or ‘dead drops’ have been a feature of the drug markets in Russia 
and Eastern European countries for some time, and with pandemic restrictions in place have become 
a more popular method in countries like the UK and Belgium. This method involves a buyer 
transferring funds to the seller, after which the drugs are left in a hidden place and the coordinates 
and a description of the hiding place are sent to the buyer to retrieve them. Home delivery, and the 
use of post and parcel systems are also on the increase. There have been reports in Ireland and other 
countries of criminals impersonating food delivery personnel in order to get past checkpoints and 




As outlined in the methodology section, recruitment to the survey was intentionally targeted at 
recreational drug users in Ireland. The HSE noted that a large number of respondents were linked with 
an advertisement in a dance music magazine. This has limited the generalisability of the findings to 
the wider drug using population and required the categorisation of the sample as people who use 
drugs recreationally. In addition, the survey covers nine drug types in detail. The HSE noted the high 
level of ketamine use among recreational users and highlighted the absence of drugs like ketamine, 
mushrooms, GHB and methamphetamines in the survey. This was also noted by respondents 
themselves in open-ended feedback. Alcohol, while mentioned, is also not covered in depth in the 
survey. 
  
                                                            





Chapter 3 Survey of Drug and Alcohol Services 
 
3.1 Overview of Survey  
 
An online survey of drug and alcohol services was conducted by the Irish Government Economic and 
Evaluation Service (IGEES) on behalf of the Department of Health, in order to estimate and profile the 
impact of COVID-19 on these services, directly and on a large scale, and to complement other evidence 
gathering and impact assessment activities being used for this rapid assessment. As outlined in Section 
1.3, services have already greatly adapted their operations in order to comply with safety measures 
due to COVID-19. This survey aimed to capture how services have altered their operations in response 
to the pandemic as well as describe the impacts COVID-19 has had on their clients. The survey was 
split into three main sections, covering different themes as outlined in the table below.  
 
Table 4 Structure of Survey of Drug and Alcohol Services 
Section Themes Explored 
A. Service 
Information 
Type and location of services, type of clients using services. 
B. Impacts of 
COVID-19 
for clients 
Health and social impacts of the pandemic for clients, impacts on drug use 
patterns and access and availability of drugs, impacts on different population 
groups who use drugs and alcohol, and impacts of COVID-19 public health advice 
and restrictions. 
C. Impacts of 
COVID-19 
for services 
Impacts on different aspects of service provision, as well as operational elements 
and governance and reporting, impacts on staff, positive impacts resulting from 






The Survey of Drug and Alcohol Service Providers in Ireland was conducted solely online due to the 
efficiency of this method and the restricted timelines of the rapid assessment methodology. The 
survey was created and hosted on EUSurvey17 - the same survey tool employed by the EMCDDA - by 
IGEES/Research Services and Policy Unit staff in the Department of Health. Drug and alcohol services 
in Ireland were invited to take part via email.  
 
Sample and data collection 
An email invitation to participate in the survey was issued by the Research Services and Policy Unit in 
the Department of Health and was sent to over 500 email addresses for drug and alcohol services in 
Ireland. The list of email addresses was provided by the Drugs Policy and Social Inclusion Unit. Services 
were asked to identify a suitable person to complete the survey (project leader / service coordinator 
                                                            
17 EU Survey is a survey platform supported by the European Commission, see 




or equivalent) and were then directed to the survey link. Here they were provided with a Participant 
Information Sheet, which they were required to read before continuing to the survey (see 
accompanying technical appendix). This information sheet explained in plain language; the purpose 
of the survey; that participation is voluntary; what is involved in participation; how data would be 
used; as well as providing contact details of the researchers for any questions. Each participant was 
required to give their consent to take part in the survey. Drug and alcohol services were given two and 
a half weeks to complete the survey. Reminders were issued after the first week and regularly during 
the second week to services who had not yet completed the survey. A total of 157 services submitted 
a survey response by the deadline on Wednesday 9th September 2020. Responses are therefore based 
on the first wave of COVID-19 and initial lockdown measures. A profile of responding services is 
presented in Section 3.3. 
 
Scope of the data  
This survey formed part of a rapid assessment of the impact of COVID-19 on drug trends and services 
in Ireland. As such, drug and alcohol services had a limited timeframe to fill in the survey. Survey 
findings represent the views and experiences of a small number of services who responded to the 
survey in this timeframe. There is high representation from certain service types like Community Drugs 
Projects, Family Support Services and Counselling Services, and high representation for services 
located in Dublin. Results should be interpreted with these caveats in mind.   
 
Services have also been asked to provide their views on how their clients have been impacted by the 
pandemic. This includes impacts in relation health and wellbeing, adhering to public health guidelines, 
and drug and alcohol consumption patterns. Although this information can provide an indication of 
how clients have been impacted, it is important to note that service users were not directly involved 
in the survey.  
 
Research Ethics 
Ethical approval for the survey was awarded by the National Research Ethics Committee COVID-19 on 
14th August 2020. Services were required to provide their consent to take part in the survey by ticking 
a box at the outset of the survey, this consent was recorded in the data. 
 
Analysis 
Data was downloaded from the survey platform, cleaned and anonymised. Data cleaning involved the 
following steps; conversion of text data to numerical data, generation of new variables for multiple 
response questions, the creation of subgroups for analysis and labelling of all variables. Analyses were 
then run for each question and graphs generated. These steps were performed in both Microsoft Excel 
and Stata version 16. Qualitative responses were not formally analysed for this report; however, brief 
summaries of the types of responses coming up in these questions are provided throughout Section 







3.3 Findings  
 
This section presents the findings of the survey of Drug and Alcohol Service Providers. Survey results 
are presented in graphs as frequencies throughout the report due to the fact that the total sample 
number is low, n=157 and some subgroups have very low numbers. Percentages are also used for 
illustrative purposes in the accompanying commentary. Some questions are analysed by service type.  
 
Qualitative findings 
Qualitative responses are presented throughout this section in blue boxes. It is important to note 
that these qualitative findings are presented to give an indication of the type of responses coming 
up for each question. Comments were reviewed and summarized. A formal qualitative analysis was 
not undertaken as part of this impact assessment. Findings in blue boxes represent the opinions of 





3.3.1 Service Information 
 
This section presents information in relation to the type and location of drug and alcohol services who 
responded to the survey.  
 
     Figure 18 Service type 
 
Note: A low threshold service is a harm reduction-based service where minimal demands are made 
of service users, i.e. services are offered without attempting to control users’ intake of drugs. 
                   
The above graph shows the service type(s) of the responding services. Services were able to choose 
multiple service types if applicable.  The largest group of respondents work in Community Drugs 
Projects, with n= 86, 55% respondents selecting this service type. Family Support Services and 
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respectively. Following these service types are Drug and Alcohol Task Forces and Low Threshold/Day 
services.  
 
A number of respondents selected ‘Other’ to define their service type, some examples of service types 
in this category include; youth services, mental health services, education and awareness, prison 
services and other community and day services. 
 
   
 Figure 19 Community Healthcare Organisation(s) (CHO) where service operates 
 
 
In terms of the region of responding services, respondents were asked to select the Community 
Healthcare Organisation(s) in which their service operates. Again, services were able to choose 
multiple CHOs if applicable. A total of n= 49, 31% respondents of the survey operate in CHO 7 
(Kildare/West Wicklow, Dublin West, Dublin South City, Dublin South West), with the 3 CHO’s 
representing Dublin (CHO 6, 7 and 9) selected by n=110, 70% respondents of the survey. In total, n=25, 
16% responding services operate in CHO 4 (Kerry, North Cork, North Lee, South Lee, West Cork). 
 
3.3.2 Health and social impacts of COVID-19 for clients of drug and alcohol services  
 
This section presents an analysis of results on the health and social impacts of the first wave of  COVID-
19 for clients of drug and alcohol services from the perspective of service providers. Clients were not 
directly involved in the survey. Section 3.3.2.1 covers impacts directly related to COVID-19 and public 
health measures. Section 3.3.2.2 deals with wider impacts of the pandemic on the health and 
wellbeing of clients. Section 3.3.2.3 examines impacts for certain population groups.  
 
3.3.2.1 Direct impacts of COVID-19 
 
Service providers were asked to indicate the extent they felt their clients were directly affected by 


























Figure 20 Service provider reports on how clients were impacted directly by COVID-19 
 
 
In terms of these direct effects of COVID-19, it appears clients were most affected in relation to having 
to self-isolate or cocoon, with n= 44, 28% respondents saying their clients were highly impacted by this 
aspect [red portion of graph]. A total of n=10 services, 7% reported that their clients were highly 
impacted in terms of being diagnosed with COVID-19 and n= 4, 3% services said clients were highly 
impacted in terms of hospitalisation.  
 
Taking those who were impacted to any extent [yellow and red portions of graph] it would appear that 
the majority of services (n= 133, 85%) had some experience with clients self-isolating in wave 1, just 
under half (n=72, 47%) had some experience with clients being diagnosed with COVID-19, and just over 
a third (n=54, 36%) had some experience with clients being hospitalised due to COVID-19. However, it 
is important to note that reported rates of diagnosis and hospitalisation cannot be verified against 
administrative data and are illustrative of overall impact for clients only.  
 
Figure 21 Service provider reports on challenge of adherence to public health advice for clients 
 
 
According to service providers, restrictions on meeting people and having to self-isolate or cocoon 
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restrictions. The majority of the respondents of the survey (n=114, 74%) highlighted that their clients 
found adhering to the restrictions concerning meeting people highly challenging. Just n= 4, 3% services 
felt this was not at all challenging for their clients. Over two thirds (n=103, 68%) reported their clients 
found self-isolating/ cocooning highly challenging, with n=8, 5% services reporting this was not at all 
challenging for clients. 
 
Nearly half of respondents (n=69, 45%) conveyed that their clients found the travel restrictions highly 
challenging. Physical distancing was similarly challenging, with n=67, 44% of services reporting that 
physical distancing was highly challenging for clients. There were however higher proportions of 
services reporting that these elements were a lower challenge for clients.  
 
Fewer respondents, but still a considerable proportion, said that their clients found wearing face 
masks highly challenging (n=56, 36%). Hand washing and cough etiquette were less challenging for 
clients. A total of n=42, 27% services reported that adhering to hand washing guidelines was not at all 
challenging for their clients. While n=45, 29% said the same for adhering to cough etiquette. However, 




Other Challenges of Public Health Advice 
Respondents were given the opportunity to specify if there were any other elements of COVID-19 
public health advice that their clients found challenging. Responses are summarized. 
 
Several services highlighted that the loss of contact, reduced services and lack of routine due to 
public health guidance were very challenging for their clients. Some respondents reiterated the 
difficulty for their clients in terms of restrictions on meeting people and the loss of social 
connections. Restrictions on meeting people and physical distancing also impacted directly on the 
services available to clients, with group sessions or meetings not able to go ahead in many cases.  
One service mentioned that some clients do not have access to the technology required for online 
versions of sessions.  
 
A few services highlighted that clients struggled with the regular changes to restrictions and public 
health guidelines. One service noted the particular challenge in this respect for clients who do not 
have access to news sources. Another service noted that the changing guidelines were challenging 
to interpret and implement for services themselves. A few services noted that some of their clients 
expressed disbelief in the existence of COVID-19. 
The fact that some social welfare payments changed from weekly to fortnightly was also mentioned 









3.3.2.2 Impacts of COVID-19 on health and wellbeing of clients 
 
 




Service providers were next asked to indicate to what extent they had observed a positive or negative 
change to their clients’ health and wellbeing since the outbreak of COVID-19. Overall clients’ physical 
and mental health, family relationships and financial circumstances were negatively affected by the 
COVID-19 pandemic. The mental health of clients was the worst impacted by the pandemic according 
to service providers, with n=149, 96% reporting a negative impact. Just n=7, 5% services felt that 
COVID-19 brought no change or a positive change to their client’s mental health.   
 
A majority of service providers also highlighted that COVID-19 had a negative impact on their client’s 
family relationships (n=129, 83%). Only n=14, 9% respondents saw no change to these relationships, 
with an even smaller proportion conveying there was a positive impact on family relationships (n= 8, 
5%). 
 
About two thirds of survey respondents felt the physical health of their clients was negatively affected 
by COVID-19 (n=106, 68%). A total of n= 33, 21% services saw no change in the physical health of their 
clients and n= 10, 7% services saw a positive change. Similarly, n=102, 66% of respondents conveyed 
that their client’s financial situation was negatively affected by COVID-19. Nearly a quarter of service 
providers saw no change (n=36, 23%) and only n= 6, 4% responding services felt COVID-19 had a 












































Figure 23 Service provider reports on clients’ experience of adverse outcomes associated with COVID-19 
 
 
Services were also asked to what extent their clients had experienced the above adverse outcomes 
due to the pandemic. Difficulty coping with social isolation was the most prevalent negative impact 
among clients according to service providers, with n=113, 73% services reporting their clients were 
impacted highly in relation to this. This was followed by an increase in domestic violence and drug 
related intimidation and violence with n= 60, 39% and n= 56, 36% services respectively, reporting high 
impacts for their clients. There were less services reporting that clients were highly impacted by 
increased overdoses (n=29, 19%) and drug related deaths (n=11, 7%) during the first wave.  
 
Taking lower and higher impacts together the number of services reporting these adverse outcomes 
for their clients increases substantially. A total of n=150, 97% of services said clients were impacted in 
relation to difficulty coping with social isolation, n=114, 74% services reported clients were impacted 
by an increase in domestic violence, n= 111, 72% services said clients were impacted in relation to drug 
related intimidation and violence, n= 87, 57% reported their clients were impacted in relation to 
increased overdoses and n=56, 37% services reported that their clients were impacted by increased 
drug related deaths.  
 
There were also considerable numbers reporting that they didn’t know how their clients were 
impacted in terms of these adverse outcomes of COVID-19, demonstrating the difficulty of measuring 
some of the wider impacts of the pandemic. 
 
 
3.3.2.3 Impacts for population groups 
 
The below graph depicts the extent to which different population groups were impacted by the 
pandemic, according to the responding services and based on their service experience during the first 
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Figure 24 Impacts of COVID-19 for population groups 
 
These population groups are ranked based on the proportion of services who reported higher impacts when Don’t know 
responses are excluded.  
 
The level of ‘Don’t know’ responses are particularly noteworthy for this question. A total of n=90 
services or above returned don’t know responses in relation to sex-workers, the Roma community and 
the LGBTI community, indicating these groups are not well represented in drug and alcohol services.  
According to service providers, the homeless community were the most affected population group 
during the COVID-19 pandemic. A total of n= 92, 65% services said the homeless community’s health 
and wellbeing was highly impacted. 
Respondents felt women were also impacted greatly by the pandemic. A total of n=87, 60% reported 
that women were impacted highly. Over half of the respondents also thought older people were 
impacted highly by the COVID-19 pandemic (n=75, 52%).  
 
Other Groups 
Respondents were also given the opportunity to specify other groups they felt had been impacted 
by the pandemic, responses are summarised below. 
Many services highlighted that the families of people who use drugs and alcohol were particularly 
impacted during the COVID-19 pandemic. Services highlighted that children of substance users 
were exposed to unhealthy environments and were confined to the home when schools were 
closed. Migrants and those in Direct Provision centres were mentioned by several services as being 
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3.3.3 Consumption of Drugs and Drug Markets 
 
This section presents an analysis of results on the impact COVID-19 has had on drug and alcohol usage 
patterns and the availability of drugs, according to service providers.  
 
Figure 25 Service provider reports on changes to client's usage behaviour 
 
 
Services were asked to what extent they had observed the above changes to their client’s behavior 
since the start of the COVID-19 pandemic. Increased alcohol consumption was the most prevalent 
change observed. A total of n=104, 68% services reported that they have observed increased alcohol 
consumption to a high extent among their clients. Rates of clients relapsing also appear to be high, 
with n=71, 48% services reporting this behaviour to a high extent. 
 
A total of n= 61, 42% services reported that clients are increasing drug use to a high extent. There are 
a similar number of services reporting that clients are using different ways of accessing drugs (n=58, 
39%), using new combinations of drugs (n=51, 34%) and using alternative drugs (n=47, 32%) to a high 
extent. Greater uptake of methadone/OST is being reported by a lower number of services, despite a 
large increase in the national provision of opioid substitution treatment during this time. This is likely 
due to the type of responding services, for example with a low number of HSE addiction services in 
the sample. Furthermore, n=32, 22% services reported that they don’t know if clients are taking up 
OST.  
 
There are also a considerable number of services reporting that they don’t know the extent that clients 
have been engaging in new risk taking behaviours and self-detoxing without supervision. Just n=8, 6% 
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New risk taking behaviours 
Respondents were given the opportunity to specify any new risk taking behaviours that their clients 
are engaging in, these are summarised here. 
 
The main new risk taking behaviours being reported by services are in relation to new consumption 
patterns and not adhering to public health guidance. Many services highlighted that due to various 
access issues their clients are taking new drugs, new combinations of drugs, engaging in poly drug 
use, and mixing drugs or prescribed medications with alcohol. Several services mentioned an 
increase in street tablet usage, while a few services mentioned the emergence of nitrous oxide use.  
 
Many services also highlighted clients’ risk taking in relation to public health guidance. Clients are 
attending house parties where they are mixing with lots of people and sharing drug paraphernalia, 
this was particularly the case among younger users. Some clients are travelling outside their 
restricted areas to source drugs. 
 
A few services highlighted an increase in drug related criminal activity, both in order to source 
money for drugs and crimes committed while under the influence. For example, a few services 





Figure 26 Service provider reports of changes to the illegal drug market since the start of COVID-19 
 
 
Drug and alcohol services were asked to indicate if they had heard reports from clients or other service 
providers of any of the above drug market changes since the start of the pandemic in Ireland in March 
2020. There are a high number of services selecting a Don’t know response for this question, results 
provide an indication of possible market changes only. 
While a small number, n= 15, 11% services, had heard reports to any extent [yellow and red portions 
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colleagues of increases in the price of drugs. Over half (n=82, 57%) had also heard reports of a drop in 
the quality of drugs during the COVID-19 pandemic, though quality was not formally assessed. 
A total of n=108, 73% services have heard reports of difficulty accessing drugs. As such, it is not 
surprising that they are also reporting different methods being used to access drugs. A total of n=82, 
56% services reported hearing that drugs were being purchased via online methods. Similarly over 
half (n=84, 58%) have heard reports of drug exchanges moving to homes, n=63, 43% have heard of 
‘drug drops’ being used to eliminate face to face contact and n=57, 40% services have heard reports 
of home deliveries of drugs through the postal service.  
 
3.3.4 Impacts of COVID-19 on Service Delivery and Use  
 
This section presents an analysis of results on the impacts the pandemic has had on various aspects 
of service delivery, operations and staff as well as the different methods that are being taken to 
overcome these challenges. Section 3.3.4.1 covers impacts on service delivery and the methods 
employed by services to overcome the challenges of the pandemic. Section 3.3.4.2 deals with impacts 
on operational elements of services, governance and reporting, and impacts on staff. Section 3.3.4.3 
covers any positive impacts of the COVID-19 pandemic and the supports received by services. Finally, 
Section 3.3.4.4 focuses on the restoration of services and remaining challenges in this regard. 
 
3.3.4.1 Impacts on service delivery and methods to overcome challenges  
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Responding services were asked to rate the overall impact the pandemic has had on their service. 
Overall, n=116, 74% of respondents to the survey felt their services were highly or extremely impacted 
by COVID-19 with a further, n=40, 25% reporting lower level impacts.  
 
The overall impact of the pandemic was also analysed by service type. There are very low numbers in 
some service type subgroups and so results should be interpreted cautiously. HSE Addiction Services, 
Drug and Alcohol Task Forces and Residential Treatment Services reported the biggest impacts of the 
pandemic with over 80% of respondents from these service types reporting a higher overall impact 
[red portion of graph]. GP addiction services reported slightly lower impacts than other service types, 




Figure 28 Impacts on aspects of service delivery for applicable services 
 
*Those selecting ‘Not applicable’ have been removed from analysis, numbers selecting this option are presented in 
brackets. 
 
The above graph depicts the extent to which various aspects of service provision have increased or 
decreased for clients. There were a greater number of services reporting increases than decreases in 
terms of the number of people using services, n=70, 46% of services said the numbers using their 
service have increased, compared to n=56, 37% who reported a reduction in service users.  
 
There were about the same number of services reporting increases and decreases in terms of hours 
of service provision, with a further n=50, 36% reporting no change. The provision of harm reduction 
equipment/services saw slightly more decreases than increases, with n=41, 41% reporting this service 
has decreased for clients, compared with n=33, 33% reporting increases in harm reduction services.  
 
A majority of respondents reported that there were decreases in the availability of existing services 
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Table 5 Percentages and frequencies of reductions in aspects of service delivery by service type  
 % (n) 
reporting 
reductions in 
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Note: Those selecting ‘Not applicable’ have been removed from analysis  
 
The above table shows the percentage and number of services who reported reductions in the listed 
aspects of service provision by service type. This allows for an indication of the services worst affected 
in relation to each aspect of service provision, though this analysis should be interpreted cautiously 
given the low numbers in some service types. The majority of all service types saw reductions in face 
to face contact with clients, however Drug and Alcohol Task Forces experienced the largest reduction 
with n=29, 97% of this service type reporting face to face contact with clients was reduced during the 
pandemic.  
 
In terms of availability of services, Drug and Alcohol Task Forces (n= 28, 93%), Family Support Services 
(n=49, 94%) and Service Users/ Peer Support Services (n=20, 95%) reported the highest proportions 
of reduced availability of the existing services offered to clients. Of those reporting reduced numbers 
of people using services, HSE Addiction services (n=7, 54%) and Residential Treatment Services (n=8, 
67%) saw the biggest reductions compared to the total sample (n=56, 37%).  
 
Drug and Alcohol Task Forces (n=11, 50%), Service Users/ Peer Support Services (n=8, 50%) and in 




harm reduction equipment or services to clients. However it has been noted by the HSE that 
Residential Treatment Services are not typically engaged in providing harm reduction equipment. 
Residential Treatment Services were also less likely than other service types to experience reductions 
in service hours (n=2, 22%). 
 
 
          Figure 29 Methods employed by services to overcome the challenges of COVID-19 
 
     
To overcome the challenges in providing services to clients during COVID-19, service providers had to 
adapt and employ new methods. The above graph shows the overall results for the methods that 
services employed. The table below shows the number and percentage of services who employed 
these methods for each service type. Although numbers are low for some service types and should be 
interpreted cautiously, this gives an indication of how different service types responded to the 
challenges of COVID-19.  
 
Given the ready access to telephone and online means of communication, along with the detailed 
guidance on remote consultations that have been drawn up for addiction services, it is not surprising 
that the majority of services are conducting consultations, counselling or key working either by 
telephone or online in light of COVID-19. A total of n=146, 93% services surveyed conducted this type 
of work on the telephone. Rates are as high as 100% for telephone consultations, counselling or key 
working by Family Support Services and GPs. Online consultations, counselling or key working was also 
used by the majority of services, with n=126, 80% of respondents overall using this method. This rose 
to 94% (n=50) for Family Support Services and 95% (n=20) for Service Users/Peer Support Services.  
 
The use of video conferencing was not as high as telephone and online, though was still employed by 
n=100, 64% of services. This would be more appropriate for services providing group sessions and was 
used most by Residential Treatment Services (n=9, 75%), Service user/Peer Support Services (n=16, 
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Table 6 Percentages and frequencies of method used by service type 
 
 
The use of PPE is also high with n= 117, 75% services using protective equipment, which was aided by 
the fact that 62% of the responding services received PPE during the pandemic (See supports received 
by services Section 3.3.4.3). Usage of PPE was highest among GP addiction services (n=5, 100%), HSE 
addiction services (n=13, 100%), Residential Treatment Services (n=11, 92%) and Low Threshold/ Day 
Services (n=24, 86%) which all typically provide some form of healthcare as part of their service. 
 
Over half (n=84, 54%) of those surveyed employed physical distancing measures in their 
clinics/treatment centres, with higher rates in particular among HSE Addiction Services (n=11, 85%) 
and Residential Treatment Centres (n=9, 75%).  
 













































































































































































































































































There were lower numbers employing methods like appointment letters, medication delivery, needle 
and crackpipe exchange services and electronic transfer of prescriptions which would be relevant to 
particular services only. A third of service providers (n= 52, 33%) sent out appointment letters to their 
clients to ensure they would be allowed unrestricted travel for attendance. Appointment letters were 
most relevant for Residential Treatment Services (n=9, 75%) and HSE Addiction Services (n=7, 54%). 
Faster induction to treatment services also helped some services to overcome challenges associated 
with COVID-19, and this was employed by n=49, 31% of services. Faster induction into treatment 
programmes was most relevant to HSE Addiction Services and Low Threshold /Day Services, being 
used by n=7, 54% and n=16, 57% respectively of these service types.  
 
Home delivery of medications or take-home medication (overall n=38, 24%) was most relevant for HSE 
(n= 7, 54%) and GP addiction services (n=2, 40%), with detailed guidance provided by the HSE on 
dispensing medication for clients in isolation during COVID-19. HSE addiction services and GPs were 
again the service types to employ electronic transfer of prescriptions to the highest degree. This 
change permits the transfer of a prescription between the prescriber and dispensing pharmacy by 
electronic means, thus being most relevant to those providing medical/prescribing services.   
 
In Ireland, needle exchange services are delivered in a number of ways including fixed-site locations 
like clinics or Community Pharmacies and new interventions like Backpacking Outreach programmes10. 
Needle and crackpipe exchange services (overall n=26, 17%) were provided in the highest proportions 
by HSE Addiction Services (n=6, 46%), GP addiction services (n=2, 40%) and Low Threshold /Day 
Services (n=11, 39%). According to new HSE guidance18, a broader harm reduction approach was to 
be considered by services delivering interventions during the pandemic. Harm reduction advice in the 
context of the pandemic should include information on the risk of COVID-19 transmission through 




Other methods employed by services 
Respondents were also given the opportunity to specify other methods they used to overcome the 
challenges of the pandemic.  
 
Several services continued to support their clients through outreach initiatives. A few services met 
clients in open spaces like public parks or conducted walk and talk sessions. A few services called to 
their clients’ gardens or gates where they could maintain socially distant but still provide a face to 
face service. A few services provided delivery of essential items or transport as required. Several 
services mentioned adapting their premises or practices to meet public health requirements. 
Finally, a few services kept in contact with their clients by posting them materials or mobile phones 
to help them continue their programmes.  
 
 
                                                            






3.3.4.2 Impacts on operations, governance and staff 
 
Figure 30 Impacts on operational elements of services 
 
 
Respondents were also asked to reflect on how COVID-19 had affected operational elements of their 
services. Work practices and work planning were hit hardest by the pandemic, with n=107, 69% and 
n=105, 68% services respectively reporting that these operational aspects were impacted highly by 
COVID-19. 
 
About a third (n=52, 34%) reported that operating costs were impacted highly, while n=44, 29% said 
resources/income were impacted highly by the pandemic. However, n=39, 26% services reported no 
impact on resources/income. 
 
 
Figure 31 Impacts on governance and reporting 
 
*Those selecting ‘Not applicable’ have been removed from analysis, numbers selecting this option are presented in brackets.  
Note 1: The NDTRS – National Drug Treatment Reporting System is a database on treated drug and alcohol misuse in 
Ireland and records incidence of drug and alcohol treatment. Service providers across Ireland report to the NDTRS. 
Note 2: Some drug and alcohol services receive funding from multiple sources, including the HSE, Drug and Alcohol Task 
Forces, the Department of Health and the Department of Justice and Equality and may be required to return reports/data 
to these funders.  
 
 
The ability of services to report to various bodies was analysed for those services for which each type 
of reporting was applicable. With this type of reporting being important for health service planning 
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pandemic down the line. A total of n= 51, 39% services highlighted that the ability to report to the 
NDTRS was not at all affected by COVID-19. About a fifth of services (n=27, 21%) said that their ability 
to report to the NDTRS was impacted highly.  
 
Nearly half of service providers (n=55, 46%) reported that their ability to report HSE KPIs wasn’t 
impacted at all by COVID-19. A total of n= 15, 13% services said their reporting ability was impacted 
highly. Similarly, n=49, 47% services reported there was no impact from COVID-19 on their ability to 
provide other key funder reports e.g. probation or DOJ. Just n= 12, 11% services felt their ability to 
provide such reports was impacted highly by COVID-19.  
 
Figure 32 Impacts on staff of drug and alcohol services 
 
 
Services were also asked to indicate the effect the pandemic has had on their staff. Overall, the biggest 
impacts were in relation to staff working from home and work life balance. Half of responding services 
(n= 78, 50%) highlighted that COVID-19 had a high impact in relation to staff working from home. Staff 
work-life balance has also been impacted to a large degree, with n= 68, 45% saying work life balance 
has been impacted highly, though it is not possible to determine if work life balance has been 
negatively or positively affected.  
  
Staff have also been impacted considerably in relation to concerns about safety, n=62, 40% service 
reported COVID-19 has had a high impact in terms of staff concerns about safety. Staff supervision 
and support and staff redeployment have been somewhat less impacted by the pandemic, with n=36, 
24% and n=35, 23% respectively reporting their staff have been impacted highly in relation to these 
factors.   
 
In comparison to the above factors, staff absence/illness and staff retention issues were less impacted 
by the COVID-19 pandemic. A total of n=65, 43% of respondents said their staff were not impacted at 
all by staff absence/illness. Staff retention is not a problem for most services, n=110, 73% services 














































Staff redeployment to other duties
Staff supervision & support
Staff concerns about safety
Staff work-life balance
Staff working from home
Not at all A little To some extent Quite a lot Very much so Don't know




3.3.4.3 Positive impacts of the COVID-19 pandemic and supports received by services 
 
Figure 33 Positive impacts of COVID-19 for drug and alcohol services 
 
 
Just n= 8, 5% services reported no positive impacts of wave 1 of COVID-19 on their service. The 
majority of respondents (n=129, 83%) found new ways of delivering services due to the COVID-19 
pandemic and nearly two-thirds (n=99, 64%) services said that the cooperation between service 
providers was a positive impact of COVID-19. A total of n= 98, 63% of service providers saw new clients 
presenting to their services and n=68, 44% service providers reported developing new services due to 
the pandemic.  
 
 
Other positive impacts 
Respondents were also given the opportunity to specify any other positive impacts their service had 
experienced as a result of COVID-19, these responses have been summarised. 
  
Several services conveyed that their ability to adapt to the COVID-19 pandemic, was in itself a 
positive impact, demonstrating how they could be creative with their services. A few services 
mentioned that conducting more outreach services out of necessity allowed them to see the 
benefits and they are now intent on continuing increased outreach services going forward.  
 
A few services mentioned the positive impacts of using online solutions, moving some of their 
services online reduced waiting lists and was of benefit to clients who didn’t have to travel to these 
sessions. Services were also able to interact online with other agencies which they found more 
efficient. 
 
A few services mentioned the increased co-operation, communication and collaboration between 




































The vast majority of responding services received some form of support during the first wave of the 
pandemic, with n=4, 3% services reporting they received none of the presented supports. Further, n= 
131, 83% services conveyed that they received public health guidance, n= 121, 77% received access 
to relevant information and n= 116, 74% received communication from statutory agencies. A total of 
n=98, 62% of the responding services received PPE during the pandemic and just under half of the 




Respondents were given the opportunity to specify any additional supports received during the 
pandemic.  
A few services highlighted that they received excellent communication and support from their CHO 
and local communities. Regular interaction with local authorities, task forces and other services 
ensured services were up to date on guidance, redeployments and resources. Cooperation between 
services and community voluntary action benefitted clients. 
 
 
3.3.4.4 Restoration of services and remaining challenges 
 
Services were asked to reflect on the extent to which the below factors represented challenges to 
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Figure 35 Challenges faced by respondents in restoring their service 
 
 
The availability of back up/support services was the top rated challenge, with n= 65, 43% services 
rating this as a highly challenging. However, social distancing had the highest proportion of extremely 
challenging ratings [dark red portion of graph], with n=26, 17% services reporting that social distancing 
measures would be extremely challenging for them in restoring their services.   
Staff training and support and new patterns of drug and alcohol use were considered less challenging 
than other factors. New patterns of use were considered not at all challenging for restoring services 
by n= 29, 19% and staff training/support was considered not at all challenging for restoring services 
by n= 26, 17% services. 
Contingency planning for future outbreaks, financial costs and social distancing are all considerable 
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Respondents were also given the opportunity to specify any other challenges that they faced in 
restoring their services, these responses are summarised here.  
The main challenges raised by services are in relation to staffing and resources. Many services 
highlighted the need for additional resources and staffing in order to cope with the increased 
demand for services and the reduced capacity due to compliance with public health guidelines. 
Some services mentioned experiencing reductions in the availability of staff due to factors like 
redeployment, child minding requirements, absence and underlying health conditions. A few 
services highlighted that these challenges are also contributing to increased waiting lists for clients 
trying to access services. 
Several services highlighted that their premises are no longer suitable with the new requirements 
for social distancing. It was noted that adaptations or hiring of space would be required to restore 





                           Figure 36  Service provider views on whether new services are needed in light of COVID-19 
 
Services were also asked to reflect on whether new or additional services were needed in light of the 
continuing impact of COVID-19. The majority of responding services felt that new drug and alcohol 
services or initiatives will be needed (n=109, 73%), with just over a quarter of respondents (n= 41, 






associated with PPE, sanitation measures, and IT equipment were mentioned by a few services as 
putting pressure on already limited budgets.  
Other challenges mentioned by a few services include limited access to appropriate technology 
and broadband, as well as, the worsening mental health of clients due to the pandemic. 
New services 
Respondents who felt new services were needed were asked to specify what type of services 
these would be. Responses are summarised. 
 
In the future, many services would like to see online counselling and services continuing to be 
online, with further training and equipment required for workers. Clients will also need to be 
supported in how to use IT services.  
Several services called for an increase in services available for alcohol users, with a big increase in 
clients presenting with alcohol problems since the pandemic. Similarly, several services 
highlighted the need for dual diagnosis services to support clients with mental health difficulties 
alongside substance use, this is particularly relevant given the negative impact the pandemic has 
had on the mental health of clients.  
New or additional outreach services, after hours services, family support services, community-
based services, harm reduction services and residential services were all mentioned by a few 






Health and Wellbeing  
According to service providers, clients’ physical and mental health, family relationships and financial 
circumstances have all been negatively affected by the COVID-19 pandemic during the first wave. 
Nearly all services (96%) reported that the mental health of clients was negatively impacted. Clients 
have also experienced other negative impacts of the pandemic: with many clients viewed as vulnerable 
they have had to isolate or cocoon and have had difficulty coping with this isolation. Many services 
have reported an increased prevalence of domestic violence among their clients, as well as increases 
in drug related violence. Some services have reported increases in overdoses and drug related deaths.  
 
These trends reflect population-level trends in the impact of COVID-19. According to the CSO Social 
Impacts of COVID-19 Survey, the population as a whole are experiencing negative impacts due to the 
pandemic, with reductions reported in life satisfaction and satisfaction with personal relationships, 
and increases in those reporting feeling downhearted and depressed. A total of 6% of the general 
population are concerned about violence in the home.  
 
Substance Use 
Drug and alcohol services have reported considerable incidences of clients using new combinations of 
drugs, using alternative drugs, engaging in new risk taking behaviours and to an even greater extent, 
increasing their alcohol consumption. Again, there have been changes to alcohol consumption on a 
population level, results of the CSO Social Impact of COVID-19 Survey19 show that of those who drink 
alcohol, 17% reported reduced alcohol consumption, and 22% reported increased alcohol 
consumption since the outbreak of COVID-19. 
 
Service Demands and Responses to COVID-19 
Overall and according to service providers there was an increased demand on services during the first 
wave of COVID-19, but less capacity to provide services due to the restrictions that have been 
necessary to put in place to manage the risks of COVID-19. According to service providers there have 
been increased numbers attending services and, some people who use drugs recreationally have 
reported increased intentions to seek support.  
 
Drug and alcohol services, like other healthcare providers, were faced with the challenge of providing 
continued care for their clients while also adhering to public health guidance, reducing face to face 
contact, restrictions on travel and social distancing measures. Services have adapted innovatively to 
these challenges, prioritizing the continuity of care for those who are opioid dependent, faster 
processing of clients into treatment, stabilization of drug use in isolation and providing COVID-19 
prevention information as part of outreach services. Temporary changes to regulations have allowed 
clients to continue to access their treatments and other medicines. Services have also adapted to 
remote working practices and employed physical distancing and PPE in their premises. Some services 
saw the positives of these adaptations, 83% of services reported that new ways of delivering services 
                                                            





has been a positive impact of the pandemic. The uptake of online solutions has been a particular 
success of the pandemic and should be supported for services, in the context of the ongoing pandemic 
and increased demands on services. 
 
Limitations  
As outlined in the methodology section, there were a number of limitations of the research that should 
be addressed. In terms of the sample, there was a high response rate from services located in the 
CHOs covering Dublin and a lower representation from rural areas. There was also a high response 
rate from certain service types, with a low number of HSE Addiction Services for example represented. 
The timing of the survey may have impacted on the ability of some services to respond. The HSE has 
noted that HSE Addiction Services continued to operate throughout the first wave of the pandemic 
whereas other services reduced their services or stopped altogether. Having a larger representation 
of HSE services could therefore have had significant impacts on results. There appears to also be low 
representation from services providing OST in the sample, considering that changes to OST were a 
vital part of the response to the pandemic, this is also a limitation of the sample achieved. Finally, 
although drug and alcohol services have provided their view on impacts for their clients, service users 






The objective of the studies detailed in this report was to provide findings on the impacts of the COVID-
19 pandemic in Ireland on people who use drugs recreationally and for drug and alcohol services and 
their clients. In particular the report aimed to; describe the current context, and any guidance that 
have been issued to drug and alcohol services in response to the COVID-19 pandemic; profile how 
people who use drugs recreationally have been impacted by COVID-19; profile the ways services have 
altered their operations and the effects this has had on service provision, staff, and resources; describe 
how drug and alcohol services believe their clients have been impacted by the pandemic; and finally 
to use results from both surveys to get a broader picture of the impacts of the pandemic for different 
groups of people who use drugs and alcohol, and drug and alcohol services. 
 
The Survey of Recreational Users provided valuable insight into how people who use drugs 
recreationally have been impacted by the pandemic. In relation to consumption, the pandemic 
appears to have brought about reductions in the use of drug types typically used in night life settings 
like cocaine and ecstasy/MDMA. There appears to have been difficulties with access since the 
pandemic, particularly for certain drugs types, with price increases resulting. There have also been 
some changes in modes of access, with respondents buying in larger quantities and less frequently, 
using different dealers and reducing face to face collection. The findings also indicated that some 
recreational users intend to access services in relation to their drug use.  
 
The Survey of Drug and Alcohol Services has highlighted the impacts of the COVID-19 pandemic on 
service capacity, staff, operations, and governance and reporting. Services provided information on 
how they adapted to the challenges of COVID-19 by employing the likes of online or telephone 
communication methods and public health measures like PPE and physical distancing, as well as the 
challenges that remain such as the availability of support services, contingency planning for future 
outbreaks, implementing social distancing in their premises and the financial costs of new equipment. 
Survey findings have also provided an indication of the negative impacts the pandemic has had on the 
health and wellbeing of clients and on their consumption behaviours.  
 
The findings of this report should be considered in conjunction with other elements of the rapid impact 
assessment methodology, including the HRB evidence brief20, and the report of case study research 
[to be published]. This report has provided perspectives from recreational users and service providers 
however, the direct voice of service users is not represented in this report. Considering that people 
using drug and alcohol services typically have different needs to those using drugs recreationally, it 
could be of value for further research to involve this group more directly. Other avenues of further 
research could involve particular service types. The small representation from HSE, GP addiction 
services and other health-based services, as well as rural based services could be addressed.  
Education type services are also likely to have experienced different impacts from COVID-19 and this 
could be explored in future.  
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